269 related articles for article (PubMed ID: 2864398)
1. Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor.
Schulz DW; Stanford EJ; Wyrick SW; Mailman RB
J Neurochem; 1985 Nov; 45(5):1601-11. PubMed ID: 2864398
[TBL] [Abstract][Full Text] [Related]
2. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
[TBL] [Abstract][Full Text] [Related]
3. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
[TBL] [Abstract][Full Text] [Related]
4. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
Makman MH; Dvorkin B
Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
[TBL] [Abstract][Full Text] [Related]
5. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
Maroto R; López MG; del Valle M; Naranjo JR; Mellström B; García AG
Mol Pharmacol; 1995 Jan; 47(1):40-50. PubMed ID: 7838132
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors.
Dubois A; Savasta M; Curet O; Scatton B
Neuroscience; 1986 Sep; 19(1):125-37. PubMed ID: 2946980
[TBL] [Abstract][Full Text] [Related]
7. Specific [3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: role of disulfide and sulfhydryl groups.
Dewar KM; Reader TA
J Neurochem; 1989 Feb; 52(2):472-82. PubMed ID: 2463335
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of dopamine receptors in insect (Apis mellifera) brain.
Kokay IC; Mercer AR
Brain Res; 1996 Jan; 706(1):47-56. PubMed ID: 8720491
[TBL] [Abstract][Full Text] [Related]
9. Stereospecific binding of a new benzazepine, [3H]SCH23390, in cortex and neostriatum.
Brière R; Diop L; Gottberg E; Grondin L; Reader TA
Can J Physiol Pharmacol; 1987 Jul; 65(7):1507-11. PubMed ID: 2889517
[TBL] [Abstract][Full Text] [Related]
10. Specific [3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: evidence for heterogeneities in affinity states and cortical distribution.
Reader TA; Brière R; Gottberg E; Diop L; Grondin L
J Neurochem; 1988 Feb; 50(2):451-63. PubMed ID: 2961849
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.
Savasta M; Dubois A; Scatton B
Brain Res; 1986 Jun; 375(2):291-301. PubMed ID: 2942221
[TBL] [Abstract][Full Text] [Related]
12. Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum.
Flaim KE; Gessner GW; Crooke ST; Sarau HM; Weinstock J
Life Sci; 1985 Apr; 36(15):1427-36. PubMed ID: 2858801
[TBL] [Abstract][Full Text] [Related]
13. [3H]SCH39166, a D1 dopamine receptor antagonist: binding characteristics and localization.
Wamsley JK; Hunt ME; McQuade RD; Alburges ME
Exp Neurol; 1991 Feb; 111(2):145-51. PubMed ID: 1824938
[TBL] [Abstract][Full Text] [Related]
14. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.
Beckstead RM; Wooten GF; Trugman JM
J Comp Neurol; 1988 Feb; 268(1):131-45. PubMed ID: 2964456
[TBL] [Abstract][Full Text] [Related]
15. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
17. Effects of sodium, lithium, and magnesium on in vitro binding of [3H]SCH23390 in rat neostriatum and cerebral cortex.
Gottberg E; Diop L; Montreuil B; Reader TA
Neurochem Res; 1989 May; 14(5):419-26. PubMed ID: 2526301
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 receptors labelled with [3H]SCH23390 in rabbit cerebral cortex and neostriatum. Equilibrium binding, kinetics and selectivity.
Reader TA; Grondin L; Montreuil B; Dewar KM
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):617-25. PubMed ID: 2575710
[TBL] [Abstract][Full Text] [Related]
19. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands.
Charifson PS; Wyrick SD; Hoffman AJ; Simmons RM; Bowen JP; McDougald DL; Mailman RB
J Med Chem; 1988 Oct; 31(10):1941-6. PubMed ID: 3050089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]